Delivery Order SPE2D018D0006-SPE2D324F3885
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Eagle Pharmaceuticals, Inc., a for-profit manufacturer of pharmaceutical products. The contract is for the supply of the drug Ryanodex (250mg vials) to support medical readiness initiatives for government agencies. The delivery order has a firm fixed price and a potential value of $154,450.85, with performance taking place in Westwood, New Jersey. The contract is not...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Eagle Pharmaceuticals, Inc., a for-profit pharmaceutical manufacturer located in Westwood, New Jersey. The contract, valued at $5,080.62, is a firm fixed-price delivery order for the supply of 250mg Ryanodex vials, a critical medication used for treating and preventing malignant hyperthermia in high-risk patients. This contract is not associated with any set-aside designations, indicating that...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a delivery order contract to Eagle Pharmaceuticals, Inc., a for-profit manufacturer of pharmaceutical products, to provide the drug Ryanodex (250mg vials). The contract has a firm fixed price of $92,838.80 and a period of performance through April 6, 2023. This award is part of Eagle Pharmaceuticals' existing Federal Supply Schedule contract with the Department of Veterans Affairs Veterans Health Administration, which has a...
- This federal contract award is a delivery order (SPE2D018D0006|SPE2D325F5039) issued by the Defense Logistics Agency (DLA) Troop Support Medical to Eagle Pharmaceuticals, Inc. ("Eagle Pharmaceuticals"), a for-profit pharmaceutical manufacturer. The contract, valued at $5,292.66, is for the supply of 250mg vials of the drug Ryanodex, which is used to treat and prevent malignant hyperthermia in high-risk patients. This delivery order contract is not set-aside and is part of a larger...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Eagle Pharmaceuticals, Inc., a for-profit pharmaceutical manufacturer. The contract, valued at $5,080.62, is for the supply of 250mg vials of the drug Ryanodex, which is used to treat and prevent malignant hyperthermia in high-risk patients. This delivery order contract is not set aside and is part of a larger Federal Supply Schedule (FSS) contract between Eagle...
- This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Eagle Pharmaceuticals, Inc., a for-profit pharmaceutical manufacturer. The contract is for the supply of Ryanodex 250 mg vials, a critical injectable medication used to treat and prevent malignant hyperthermia. The contract has a ceiling value of $7,056.88 and an ultimate completion date of May 1, 2025. Eagle Pharmaceuticals holds a significant Federal Supply Schedule (FSS)...
- This federal contract award, valued at $5,292.66, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Eagle Pharmaceuticals, Inc. The contract is for the delivery of Ryanodex 250mg vials, a critical pharmaceutical product used to treat and prevent malignant hyperthermia in high-risk patients. The contract is a firm fixed-price delivery order with a performance period ending on February 28, 2025. This award is part of a larger Federal Supply Schedule...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed-price delivery order contract worth $5,080.62 to Eagle Pharmaceuticals, Inc. for the supply of 250mg vials of the drug Ryanodex. This delivery order, with a period of performance through November 27, 2024, supports the DLA's medical readiness initiatives for the Department of Defense. Eagle Pharmaceuticals, a for-profit pharmaceutical manufacturer, is the prime contractor on this open-market contract, which does...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Eagle Pharmaceuticals, Inc. for the supply of Ryanodex, a 250mg injectable medication used for the treatment and prevention of malignant hyperthermia. The contract has a ceiling value of $10,161.24 and is a firm fixed price delivery order that runs through August 2024. Eagle Pharmaceuticals is a specialized pharmaceutical company that provides critical medications to the U.S. federal...
- This federal contract award SPE2D018D0006|SPE2D325F7998, valued at $15,877.98, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Eagle Pharmaceuticals, Inc. The contract is for the delivery of 4567758875 - RYANODEX 250 MG VIAL, a critical pharmaceutical product used to treat and prevent malignant hyperthermia in high-risk patients. The contract is a firm fixed-price delivery order with a completion date of March 18, 2025. Eagle Pharmaceuticals, a...
- SPE2D018D0006Indefinite Delivery Contract
- SPE2D018D0006-SPE2D324F3885Delivery Order
This federal contract award to Eagle Pharmaceuticals, Inc., a for-profit pharmaceutical manufacturer, is a delivery order from the Defense Logistics Agency Troop Support Medical. The contract is for the supply of 250mg vials of the drug Ryanodex, with a firm fixed price of $1,693.54 and a completion date of January 5, 2024. The place of performance is Westwood, New Jersey. This delivery order is part of a larger Federal Supply Schedule contract held by Eagle Pharmaceuticals through the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12, which has a potential value of $30,890,560 and provides for the supply of drugs, pharmaceuticals, and hematology-related products to VA medical facilities in New Jersey, Pennsylvania, and Delaware over a five-year period. No set-aside designation or major subcontractors are indicated for either the delivery order or the larger contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 1/2/24 |